| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |